Conference Coverage
Latest News
Jan 06, 2026 | News
Claims Study Highlights Persistence and Reasons for Fenfluramine Use in Lennox-Gastaut Syndrome
Semaglutide Linked to Improved Neurological Outcomes in Large Vessel Occlusion Without IV Thrombolysis
Jan 06, 2026
FDA Action Update, December 2025: Acceptance, Approval, and Clearance
Jan 05, 2026
FDA Approves Generic Glatiramer Acetate Injection for Multiple Sclerosis Treatment
Jan 05, 2026
AI Model Distinguishes EDSS Subgroup Patterns in Multiple Sclerosis, Study Shows
Jan 05, 2026
Advertisement
Shorts
1:22
Strategies for Increasing Diversity in Brain Aging Research
5 hours ago
by
Charisse Winston-Gray, PhD, MSc(+1 more)
Media-Driven Misconceptions of Narcolepsy
a month ago
by
Julie Flygare, JD(+1 more)
0:30
Barriers to Early Diagnosis and Access to Care in MS
2 months ago
by
Ethel Ciampi, MD, MSc(+1 more)
1:30
Collaboration Within the ALS Community
2 months ago
by
Jinsy A. Andrews, MD, MSc(+1 more)
1:30
Safety Considerations for Kygevvi in Tk2d
2 months ago
by
Fabian Somers, PhD(+1 more)
1:30
Data Backing First Treatment for Tk2d
2 months ago
by
Fabian Somers, PhD(+1 more)
1:30
Training the Next Neuromuscular Specialists
2 months ago
by
John Norbury, MD(+1 more)
1:15
Evolving Landscape of Myasthenia Gravis Treatment
2 months ago
by
Leila Darki, MD(+1 more)
1:05
Aerobic Exercise and Promoting Remyelination in MS
3 months ago
by
Lindsey Wooliscroft, MD, MS(+1 more)
1:12
MDS 2025: Learning From Progress in Other Disease States
3 months ago
by
Lorraine Kalia, MD, PhD(+1 more)
Coverage of AANEM 2025
Get direct access to interviews with experts, straight from the conference floor in San Francisco, as well as the latest data and clinical news updates.
Mind Moments Podcast
Mind Moments® is a biweekly podcast from NeurologyLive that brings you exclusive interviews with expert neurologists and clinicians.
DAMM Good Sleep
Check out DAMM Good Sleep × NeurologyLive for neurology-focused sleep content to allow any neurology stakeholder to use sleep as the diagnostic, prognostic, and therapeutic neurology tool it should be.
NeuroVoices
NeuroVoices is NeurologyLive's series of in-depth, exclusive Q&A conversations with a variety of experts in the care and management of patients with neurologic diseases about topics in clinical care and therapeutic development.
Gold Standard Centers
Gold Standard Centers is our deep dive feature series on examples of institutional success in neurologic medicine, highlighting the centers that are leading the way in care.
Videos
Podcasts
Continuing Medical Education
Advertisement
All News
Advertisement
Here's some of what is coming soon to NeurologyLive® this week.
Janelle Wagner, PhD, a clinical psychologist and research professor at the Medical University of South Carolina, provided clinical insights on a recently presented study on whether elevated ADHD symptoms impact post epilepsy surgery seizure freedom.
Benjamin Greenberg, MD, MHS, a nationally recognized neuroimmunologist, spoke about the clinical impact of the latest NMOSD recommendations and their implications for diagnosis and care.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on preventative migraine therapies!
ALS expert Sabrina Paganoni, MD, PhD, provided follow-up commentary on promising phase 1 data from the LUMINA trial testing Amylyx’s novel agent AMX0114 in patients with early-stage ALS.
As part of NeurologyLive®'s Year in Review, take a look at some of the top ongoing clinical trials in Parkinson disease that may impact care.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 2, 2026.
As part of NeurologyLive®'s Year in Review, take a look at some of the top ongoing clinical trials in Alzheimer disease and dementia that may impact care.
Explore anticipated FDA decisions on groundbreaking neurology drugs in 2026, shaping treatment options for various neurologic conditions.
Margaret Rice, PhD, a professor in the Departments of Neurosurgery and Neuroscience at NYU Grossman School of Medicine, provided answers on recently published preclinical research relating aerobic exercise to dopamine release and coordination in PD.
Advertisement
As part of NeurologyLive®'s Year in Review, take a look at our top expert interviews on the latest advances and use of artificial intelligence in neurology care.
At ECTRIMS 2025, the William S. and Lois Stiles Edgerly Professor of Neurology at Yale School of Medicine discussed evolving insights into the disease pathogenesis of multiple sclerosis.
As part of NeurologyLive®'s Year in Review 2025, we've compiled some of the top trending migraine trials.
As part of NeurologyLive®'s Year in Review, take a look at our top collaborative interviews with the Strategic Alliance Partnership program in 2025.
These were the most impactful FDA approval stories that were part of our coverage in 2025, brought to you as part of NeurologyLive's Year in Review.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Approves Generic Glatiramer Acetate Injection for Multiple Sclerosis Treatment
2
FDA Action Update, December 2025: Acceptance, Approval, and Clearance
3
A Clinical Review of the 2025 Neuromyelitis Optica Spectrum Disorder Guidelines
4
AI Model Distinguishes EDSS Subgroup Patterns in Multiple Sclerosis, Study Shows
5